OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
GTCY58

Genetec Technology Bhd

Industrial Machinery & EquipmentVerified

Genetec Technology Bhd maintains a strong liquidity position, with a current ratio of 4.7 and cash and equivalents amounting to MYR 64.5 million, which is significantly higher than the industry median. The company's liquidity FPT score indicates a low risk of liquidity stress, supported by a free cash flow of MYR 17.4 million and a debt-to-equity ratio of 0.07, suggesting a conservative capital structure. Profitability metrics show a return on equity of 3.54% and a return on assets of 2.85%, which are below the industry median for industrial machinery firms. The company's operating margin is 29.5%, calculated from operating income of MYR 20.8 million on revenue of MYR 70.5 million, indicating room for improvement in cost management and pricing power. The company's revenue is concentrated in the industrial goods segment, with no disclosed geographic diversification. This concentration may expose the company to sector-specific risks, such as demand fluctuations in the semiconductor and electronics manufacturing industries. Looking ahead, Genetec Technology Bhd is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. The company's capital expenditure of MYR -24.6 million suggests a focus on asset optimization rather than expansion, which aligns with its current financial position. Risk factors for Genetec Technology Bhd are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's dilution potential is also low, as there are no signs of imminent share issuance or dilutive events. The absence of significant debt and the presence of substantial cash reserves further mitigate financial risk. Recent events, including analyst estimates and recommendations, indicate a mixed outlook. The mean price target is MYR 0.55, with a median of MYR 0.70, and the mean recommendation score is 3.33, suggesting a neutral stance from analysts. There are no strong buy recommendations, with only one buy and no hold ratings reported.

30-day price · GTCY+0.14 (+75.7%)
Low$0.17High$0.41Close$0.33As of17 May, 00:00 UTC
Profile
CompanyGenetec Technology Bhd
TickerGTCY.KL
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryIndustrial Machinery & Equipment
AI analysis

Business. Genetec Technology Bhd designs and manufactures industrial machinery and equipment, primarily serving the semiconductor and electronics manufacturing sectors.

Classification. Genetec Technology Bhd is classified under the Industrial Machinery & Equipment industry within the Industrial Goods business sector, with a confidence level of 0.92.

Genetec Technology Bhd maintains a strong liquidity position, with a current ratio of 4.7 and cash and equivalents amounting to MYR 64.5 million, which is significantly higher than the industry median. The company's liquidity FPT score indicates a low risk of liquidity stress, supported by a free cash flow of MYR 17.4 million and a debt-to-equity ratio of 0.07, suggesting a conservative capital structure. Profitability metrics show a return on equity of 3.54% and a return on assets of 2.85%, which are below the industry median for industrial machinery firms. The company's operating margin is 29.5%, calculated from operating income of MYR 20.8 million on revenue of MYR 70.5 million, indicating room for improvement in cost management and pricing power. The company's revenue is concentrated in the industrial goods segment, with no disclosed geographic diversification. This concentration may expose the company to sector-specific risks, such as demand fluctuations in the semiconductor and electronics manufacturing industries. Looking ahead, Genetec Technology Bhd is projected to maintain a stable revenue trajectory, with no significant growth or decline expected in the next fiscal year. The company's capital expenditure of MYR -24.6 million suggests a focus on asset optimization rather than expansion, which aligns with its current financial position. Risk factors for Genetec Technology Bhd are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's dilution potential is also low, as there are no signs of imminent share issuance or dilutive events. The absence of significant debt and the presence of substantial cash reserves further mitigate financial risk. Recent events, including analyst estimates and recommendations, indicate a mixed outlook. The mean price target is MYR 0.55, with a median of MYR 0.70, and the mean recommendation score is 3.33, suggesting a neutral stance from analysts. There are no strong buy recommendations, with only one buy and no hold ratings reported.
Key takeaways
  • Genetec Technology Bhd has a strong liquidity position with a current ratio of 4.7 and significant cash reserves.
  • The company's profitability metrics are below the industry median, indicating potential for improvement in cost management.
  • Revenue is concentrated in the industrial goods segment, with no disclosed geographic diversification.
  • The company is projected to maintain a stable revenue trajectory with no significant growth or decline expected.
  • Risk factors are currently low, with no immediate liquidity or dilution flags detected.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyMYR
Revenue$70.5M
Gross profit$23.3M
Operating income$20.8M
Net income$16.8M
R&D
SG&A
D&A
SBC
Operating cash flow$47.8M
CapEx-$24.6M
Free cash flow$17.4M
Total assets$591.3M
Total liabilities$116.1M
Total equity$475.2M
Cash & equivalents$64.5M
Long-term debt$31.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$97.1M-$4.0M-$4.2M-$4.7M
FY-3$223.6M$64.2M$56.4M$56.8M
FY-2$294.6M$78.1M$66.6M-$3.0M
FY-1$347.0M$90.9M$86.1M
FY0$222.7M-$24.7M-$31.4M-$56.5M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$124.4M$77.8M$31.8M
FY-3$294.2M$152.6M$31.2M
FY-2$500.5M$397.0M
FY-1$567.7M$487.5M
FY0$521.5M$435.7M
PeriodOCFCapExFCFSBC
FY-4$20.1M-$3.0M-$4.7M
FY-3-$99.6M-$4.7M$56.8M
FY-2$92.4M-$74.7M-$3.0M
FY-1$42.3M-$22.4M
FY0-$93.7M-$22.4M-$56.5M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$70.5M$20.8M$16.8M$17.4M
FQ-6$51.5M$7.0M$10.2M$11.0M
FQ-5$40.2M$5.0M$4.8M-$12.6M
FQ-4$62.6M$7.1M$6.5M$562.0k
FQ-3$75.1M$3.2M$759.0k$630.0k
FQ-2$44.8M-$39.2M-$43.4M-$45.1M
FQ-1$34.3M-$41.6M-$42.3M-$45.8M
FQ0$25.8M-$68.0M-$68.7M-$75.0M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$591.3M$475.2M$64.5M
FQ-6$567.7M$487.5M
FQ-5$549.9M$477.9M
FQ-4$564.0M$484.4M
FQ-3$546.6M$489.4M
FQ-2$521.5M$435.7M
FQ-1$522.7M$390.1M
FQ0$477.1M$321.0M
PeriodOCFCapExFCFSBC
FQ-7$47.8M-$24.6M$17.4M
FQ-6$42.3M-$22.4M$11.0M
FQ-5-$38.4M-$2.7M-$12.6M
FQ-4-$20.1M-$10.1M$562.0k
FQ-3-$56.1M-$14.4M$630.0k
FQ-2-$93.7M-$22.4M-$45.1M
FQ-1-$42.4M-$5.0M-$45.8M
FQ0-$38.3M-$12.8M-$75.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$475.2M
Net cash$33.3M
Current ratio4.7
Debt/Equity0.1
ROA2.9%
ROE3.5%
Cash conversion2.8%
CapEx/Revenue-34.9%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Industrial Goods · cohort 2404 companies
MetricGTCYActivity
Op margin29.5%6.1% medp25 1.1% · p75 11.6%top quartile
Net margin23.9%4.9% medp25 0.8% · p75 9.7%top quartile
Gross margin33.1%24.1% medp25 16.2% · p75 33.5%above median
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue-34.9%-3.9% medp25 -8.6% · p75 -1.8%bottom quartile
Debt / equity7.0%24.0% medp25 5.4% · p75 59.8%below median
Observations
IR observations
Mean price target0.55 MYR
Median price target0.70 MYR
High price target0.81 MYR
Low price target0.15 MYR
Mean recommendation3.33 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count2.00
Strong-sell count0.00
Mean EPS estimate-0.06 MYR
Last actual EPS-0.04 MYR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 01:21 UTC#0f492f12
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 02:02 UTCJob: 7f4feedd